Richard Anthony, PhD
Board memberJanus Pharmaceuticals, Inc.
Richard Anthony, PhD, is the Chief Executive Officer at Catalyst Pharma Group, Inc., California, a contract research organization providing clinical development, regulatory and licensing representative services for pharmaceutical and biotechnology companies. He also serves as the Board Member of Janus Pharmaceuticals. Dr. Anthony’s familiarity with all facets of the research process, both in the US and abroad, provides a unique perspective to understanding the clinical, regulatory, ethical, and business complexities of today's drug development environment. (This is me - Update Profile)
| 2004 - present | Board member Janus Pharmaceuticals, Inc. |
|---|---|
| 2000 - present | Chief Executive Officer Catalyst Pharma Group, Inc. |
GLG Study Groups with Richard Anthony, PhD(?)
| Study Group Name | Members |
|---|---|
| Medical Microbiologists (US) | 70 |
| Generic Drug Economic Experts | 677 |
| Council Members who Use the IDI-MRSA assay in the U.S. | 42 |
| QT Interval Prolongation Experts (US) | 49 |
GLG NewsSM Analyses by Richard Anthony, PhD(?)
Viagra (sildenafil) a same a PDE-5 same class compound as SLx-2101 has shown efficacy for Raynaud's by significantly reducing the frequency and duration of Raynaud attacks and improved capillary flow velocity by 400%, according to a study led by Roland Fries, M.D and published online...
GLG InstituteSM Seminars with Richard Anthony, PhD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Richard Anthony, PhD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms